Advertisement
Screener

PHATHOM PHARMACEUTICALS, INC. (PHAT) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

PHATHOM PHARMACEUTICALS, INC. Cash Flow Breakdown

Cash flow breakdown shows where PHATHOM PHARMACEUTICALS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $166.78M went out.
  • Fiscal year ended 2025-12-31: from investing, $229.00K went out.
  • Fiscal year ended 2025-12-31: from financing, $288.00K went out.
  • Fiscal year ended 2025-12-31: change in cash, $167.29M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew debtNew shares soldNot split outChange in cash
2025-12-31-$166.78M-$229.00K$0.00$1.64M*-$167.29M
2024-12-31-$266.77M-$135.00K$59.40M$1.60M$121.78M*-$84.13M
2023-12-31-$137.58M-$1.63M$39.32M$14.07M$314.19M*$228.37M
2022-12-31-$146.53M-$1.04M$0.00$0.00$120.04M*-$27.53M
2021-12-31-$148.46M-$328.00K-$54.13M$96.89M$1.94M-$104.08M
2020-12-31-$69.69M-$1.04M$25.00M$629.00K$88.83M*$43.73M
2019-12-31-$36.51M-$25.25M$24.85M$279.80M*$242.89M
2018-12-31-$1.02M$2.00K$1.90M*$879.00K

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew debtNew shares soldNot split outChange in cash
2026-06-30-$1.93M*-$44.00K*$0.00*$0.00*$3.55M*
2026-03-31-$15.65M-$61.00K-$229.05M$173.25M$591.00K$121.85M*$50.93M
2025-12-31-$5.00M*-$87.00K*$0.00*$1.26M*
2025-09-30-$14.12M*-$27.00K*$0.00*$293.00K*
2025-06-30-$62.73M*-$97.00K*$0.00*$0.00*$80.00K*
2025-03-31-$84.93M-$18.00K$0.00$0.00$0.00-$84.95M
2024-12-31-$63.46M*-$5.00K*$24.75M*$1.30M*
2024-09-30-$63.57M*-$44.00K*$0.00*$282.00K*$121.78M*
2024-06-30-$70.72M*-$46.00K*$24.75M*
2024-03-31-$69.02M-$40.00K$9.90M-$59.16M
2023-12-31-$43.80M*-$475.00K*$39.32M*$0.00*$172.68M*
2023-09-30-$31.91M*-$939.00K*$0.00*$0.00*
2023-06-30-$22.20M*-$6.00K*$0.00*$141.50M*
2023-03-31-$39.67M-$214.00K$0.00$14.07M*-$25.81M
2022-12-31-$41.04M*-$412.00K*
2022-09-30-$35.02M*-$134.00K*$24.60M*
2022-06-30-$25.72M*-$428.00K*
2022-03-31-$44.76M-$67.00K-$44.82M
2021-12-31-$41.26M*-$100.00K*$0.00*$0.00*$163.00K*
2021-09-30-$29.07M*-$14.00K*$1.26M*$42.76M*
2021-06-30-$28.36M*-$45.00K*$104.00K*
2021-03-31-$49.77M-$169.00K$412.00K-$49.52M
2020-12-31-$28.20M*-$124.00K*$0.00*$89.46M*
2020-09-30-$20.73M*-$183.00K*$0.00*
2020-06-30-$9.34M*-$57.00K*$0.00*
2020-03-31-$11.42M-$676.00K$25.00M$12.91M
2019-12-31-$23.38M*-$106.00K*$0.00*$192.77M*
2019-09-30-$7.11M*-$26.00K*$0.00*-$1.30M*
2019-06-30-$5.21M*
2019-03-31-$807.00K-$807.00K
2018-12-31-$302.00K*$0.00*$1.05M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Altimmune, Inc. (ALT)United States$0.593B-6.43
Monopar Therapeutics (MNPR)United States$0.598B-34.82
CytomX Therapeutics, Inc. (CTMX)United States$0.598B-10.25
CorMedix Inc. (CRMD)United States$0.605B3.25
Aquestive Therapeutics, Inc. (AQST)United States$0.606B-6.67
Indaptus Therapeutics, Inc. (INDP)United States$0.537B
IMPACT BIOMEDICAL INC. (IBO)United States$0.611B66.47
CRESCENT BIOPHARMA, INC. (CBIO)United States$0.529B-5.20
Evolus, Inc. (EOLS)United States$0.519B-13.32
Neurogene Inc. (NGNE)$0.625B-4.46